Market Place
Sourcing Support
Novartis Data In Nejm: Fabhalta Slows Kidney Decline By 49.3%
29 Mar 2026 //
GLOBENEWSWIRE
Novartis Shares Skin Relief Data at AAD 2026
23 Mar 2026 //
GLOBENEWSWIRE
Novartis Receives Positive CHMP Opinion for Remibrutinib in CSU
27 Feb 2026 //
GLOBENEWSWIRE
AI Transforms Pharma`s Financials Beyond Drug Discovery
11 Feb 2026 //
BIOSPACE
Novartis and Folia Health Partner on App-Based IgA Nephropathy Study
13 Mar 2025 //
GLOBENEWSWIRE
Novartis named first corporate pharma partner of Football League
13 Mar 2025 //
PR NEWSWIRE
Novartis shareholders approve resolutions at 2025 AGM
07 Mar 2025 //
GLOBENEWSWIRE
HMRI partners with Novartis Australia to supercharge heart health
19 Feb 2025 //
BIOSPECTRUM
Novartis runs breast cancer awareness blitz in Super Bowl ad
28 Jan 2025 //
FIERCE PHARMA
Novartis pays Schrödinger $150M to form drug discovery pact
13 Nov 2024 //
PR NEWSWIRE
Novartis` Scemblix leaps into newly diagnosed CML
30 Oct 2024 //
FIERCE PHARMA
Firefly Advances AI-Driven BNA™ Technology in Neuroscience
20 Sep 2024 //
GLOBENEWSWIRE
Stem cell therapy delivers potential for sickle cell disease
31 Aug 2023 //
EUROPEAN PHARMACEUTICAL REVIEW
J&J, Novartis, Genentech call for permanent cancer trial changes
21 Apr 2022 //
FIERCEBIOTECH
COVID tracker: Pfizer, Moderna, Novavax, Novartis and more
19 Jan 2022 //
FIERCEPHARMA
Pfizer, Novartis, & other biotechs sign onto NIH/FDA program for rare diseases
27 Oct 2021 //
ENDPTS
Looking to leave Zolgensma data manipulation scandal behind, Brian Kaspar
29 Mar 2021 //
ENDPTS
Multicenter survey results show MS patients & nurses prefer Novartis’ Kesimpta
16 Feb 2021 //
PHARMABIZ
It could be years before vaccines reach some countries — report
16 Dec 2020 //
ENDPTS
Aimovig reduces frequency of episodic migraines, five-year data reveals
06 Oct 2020 //
PHARMAFILE
Can contact lenses deliver drugs? New research team aims to answers
22 Sep 2020 //
FIERCE PHARMA
Gene therapy upstart recruits more ex-AveXis talent; I-Mab reveals half results
31 Aug 2020 //
ENDPTS
AI VIVO seeks pharma, biotech collaboration partners to advance drug candidates
10 May 2020 //
MEDICAL
Five-year data supports early treatment with Novartis` Mayzent
21 Apr 2020 //
PHARMAFILE
New data back long-term use of Novartis` Aimovig in migraine
16 Apr 2020 //
PHARMATIMES
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
26 Mar 2020 //
CONGRESS
Covid-19 roundup: Trump backtracks on NIH/CDC funding, Novartis launches $20M
18 Mar 2020 //
ENDPTS
Here are 2020`s 11 blockbuster drug launches
12 Feb 2020 //
FIERCE PHARMA
Coronavirus drugs, Sanofi, Novartis and more—FiercePharmaAsia
31 Jan 2020 //
FIERCE PHARMA
Seer raises $55M as proteomics approaches prime time in disease detection
17 Dec 2019 //
ENDPT NEWS
The pharma industry`s rep hits absolute. rock. bottom.
04 Sep 2019 //
ENDPTS
Evidence of a link between Parkinson`s disease & gut could inspire treatments
27 Jun 2019 //
FIERCE BIOTECH
Two drugs for SMA should be priced how low to be cost effective?
25 Feb 2019 //
STATNEWS
Clinigen secures the full rights to original troubled IL-2 drug Proleukin
13 Feb 2019 //
ENDPTS
Kymriah gets NICE approval for DLBCL
02 Feb 2019 //
PHARMA TIMES
Johnson & Johnson dips a toe into gene therapy
31 Jan 2019 //
EVALUATE PHARMA
Five reasons biologics contract manufacturing will hit $87.6bn by 2027
28 Jan 2019 //
BIOPHARMA-REPORTER
Clinigen to report sharp jump in revenue and profit after busy six months
14 Jan 2019 //
PROACTIVE INVESTORS
M&A, IPOs and VC raises: Biotech, medtech execs look to 2019
12 Jan 2019 //
FIERCE BIOTECH
Deciphera CBO Morl talks lines of therapy for kinase inhibitor ripretinib
11 Jan 2019 //
FIERCE BIOTECH
Novartis gets breakthrough tag from FDA for sickle cell drug
09 Jan 2019 //
C4 Therapeutics, Biogen buys more shots on goal on SMA, Alzheimer’s
04 Jan 2019 //
ENDPTS
The 20 Hottest Pipeline Drugs to Watch in 2019
03 Jan 2019 //
BIOSPACE
5 Biopharma Trends to Watch in 2019
01 Jan 2019 //
GEN
Novartis to pay Aveo Pharma $2.3M related to return of AV-380
24 Dec 2018 //
SEEKING ALPHA
Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals
20 Dec 2018 //
CALCALISTECH
Reimagining medicine? Novartis wraps pharma’s first big global pot deal
19 Dec 2018 //
ENDPTS
Novartis, struggling with Kymriah manufacturing, providing out-of-spec doses
18 Dec 2018 //
FIERCE PHARMA
Anji Pharms Licenses Regional Rights to a Clinical Asset from Global Pharma
18 Dec 2018 //
BIOSPACE
Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial
18 Dec 2018 //
REUTERS
Novartis eyes new method for funding ultrapricey next-gen drugs
17 Dec 2018 //
FIERCE PHARMA
CAR-Ts take centre stage as ASH18 comes to a close
05 Dec 2018 //
PMLIVE
Off-the-shelf cell therapy for cancer? Fate Therapeutics to make its case at ASH
30 Nov 2018 //
FIERCE BIOTECH
ASH 2018:A Guide to the Latest for Blood-Borne Cancers and More
26 Nov 2018 //
XCONOMY
Miracle Drugs Don’t Always Work— A Rare but Lethal Case of an I-O Backfire
23 Nov 2018 //
BIOSPACE
Genentech’s inhaled JAK1 inhibitor shows promise in asthma
22 Nov 2018 //
FIERCE BIOTECH
New Novartis study supports Entresto as HFrEF therapy in Heart failure
11 Nov 2018 //
PR NEWSWIRE
Novartis says SMA gene therapy is cost-effective at $4-5 mln per patient
07 Nov 2018 //
REUTERS
Coherus` newly minted Neulasta biosim steps up pressure on Amgen
06 Nov 2018 //
FIERCE PHARMA
